190 related articles for article (PubMed ID: 22819717)
1. Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion.
Ao J; Meng J; Zhu L; Nie H; Yang C; Li J; Gu J; Lin Q; Long W; Dong X; Li C
Mol Oncol; 2012 Oct; 6(5):507-15. PubMed ID: 22819717
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma.
Nie H; Cao Q; Zhu L; Gong Y; Gu J; He Z
PLoS One; 2013; 8(4):e61678. PubMed ID: 23620780
[TBL] [Abstract][Full Text] [Related]
3. Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia.
Ouyang X; Yao L; Liu G; Liu S; Gong L; Xiao Y
Biochem Biophys Res Commun; 2021 Jun; 557():26-32. PubMed ID: 33862456
[TBL] [Abstract][Full Text] [Related]
4. SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma.
Li C; Yang W; Zhang J; Zheng X; Yao Y; Tu K; Liu Q
Int J Mol Sci; 2014 Apr; 15(5):7124-38. PubMed ID: 24776759
[TBL] [Abstract][Full Text] [Related]
5. Emodin succinyl ester inhibits malignant proliferation and migration of hepatocellular carcinoma by suppressing the interaction of AR and EZH2.
Khan H; Jia W; Yu Z; Zaib T; Feng J; Jiang Y; Song H; Bai Y; Yang B; Feng H
Biomed Pharmacother; 2020 Aug; 128():110244. PubMed ID: 32464306
[TBL] [Abstract][Full Text] [Related]
6. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
7. The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.
Xu J; Lin H; Li G; Sun Y; Chen J; Shi L; Cai X; Chang C
EBioMedicine; 2016 Oct; 12():55-67. PubMed ID: 27688096
[TBL] [Abstract][Full Text] [Related]
8. Tiam1 is associated with hepatocellular carcinoma metastasis.
Huang J; Ye X; Guan J; Chen B; Li Q; Zheng X; Liu L; Wang S; Ding Y; Ding Y; Chen L
Int J Cancer; 2013 Jan; 132(1):90-100. PubMed ID: 22573407
[TBL] [Abstract][Full Text] [Related]
9. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Long Non-Coding RNA PlncRNA-1 Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
Dong L; Ni J; Hu W; Yu C; Li H
Cell Physiol Biochem; 2016; 38(2):836-46. PubMed ID: 26906068
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
[TBL] [Abstract][Full Text] [Related]
13. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
Gao L; Ge C; Fang T; Zhao F; Chen T; Yao M; Li J; Li H
J Gastroenterol Hepatol; 2015 Feb; 30(2):396-404. PubMed ID: 25090954
[TBL] [Abstract][Full Text] [Related]
14. Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression.
Dauki AM; Blachly JS; Kautto EA; Ezzat S; Abdel-Rahman MH; Coss CC
Cancer Res; 2020 Feb; 80(3):561-575. PubMed ID: 31685543
[TBL] [Abstract][Full Text] [Related]
15. MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition.
Lv G; Tan Y; Lv H; Fang T; Wang C; Li T; Yu Y; Hu C; Wen W; Wang H; Yang W
Sci China Life Sci; 2017 Nov; 60(11):1203-1213. PubMed ID: 28812296
[TBL] [Abstract][Full Text] [Related]
16. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
17. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis.
Ma WL; Hsu CL; Yeh CC; Wu MH; Huang CK; Jeng LB; Hung YC; Lin TY; Yeh S; Chang C
Hepatology; 2012 Jul; 56(1):176-85. PubMed ID: 22318717
[TBL] [Abstract][Full Text] [Related]
18. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
19. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
20. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
